Metraipolis › archive › dc_b166b611a237
Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa — Europe PMC PMID:41405200
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41405200
- DOI
- 10.1128/msystems.01384-25
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T14:16:45.347Z
- SHA-256 of the archived text
98d2397ed2ca17600f58f833121d92023269e3ac5659a5643b0bbff25f4b2746- Stable URL of this page
https://metraipolis.com/documento/dc_b166b611a237
How to cite
Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa — Europe PMC PMID:41405200 — Europe PMC (en), https://europepmc.org/article/MED/41405200 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b166b611a237 (Metraipolis archive dc_b166b611a237, sha256 98d2397ed2ca17600f58f833121d92023269e3ac5659a5643b0bbff25f4b2746)
BibTeX
@misc{dcb166b611a237,
title = {Model-informed development of bacteriophage therapy: bridging in vitro and in vivo efficacy against multidrug-resistant Pseudomonas aeruginosa — Europe PMC PMID:41405200},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41405200},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b166b611a237; sha256 98d2397ed2ca17600f58f833121d92023269e3ac5659a5643b0bbff25f4b2746},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41405200. Agents can read the archived copy with the MCP tool read_document.